Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
MedPlus Health Services informed stock exchanges that its subsidiary, Optival Health Solutions Private Limited, received a two-day suspension order on a drug license for a store located at Old City Main Road in Karnataka. The order was issued by the Assistant Director, Drugs Control Administration, Bangalore Circle – Bidar, and was received on July 10, 2025. The action was taken under Rule 65 of the Drugs and Cosmetics Act, 1940 and the related Rules, 1945. The company estimates a potential revenue loss of only about Rs. 0.53 lakhs from this brief suspension. The filing was made as a routine disclosure under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
The financial impact is negligible at around Rs. 0.53 lakhs, so shareholders should not be concerned about material damage. However, repeated license actions across stores could attract regulatory scrutiny over time, so investors may want to watch for similar filings in the future.